pharmacologically active opioid metabolites and prolonged narcosis; such patients must be
monitored for signs of toxicity. To date, this effect has only been reported with codeine,
morphine, and pethidine. Dextropropoxyphene is not recommended in renal insufficiency.29
The use of oxygen supply, highly trained nurses, monitoring to avoid respiratory and
cardiovascular adverse events is highly recommended.